Corax Consultants LLC6. Apr.1 Min.Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the BOSTON, April 05, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage...
Corax Consultants LLC6. Apr.1 Min.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NEW YORK and WALTHAM, Mass., April 05, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (“Dianthus”), a clinical-stage biotechnology...
Corax Consultants LLC6. Apr.1 Min.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage...
Corax Consultants LLC6. Apr.1 Min.Precision Biologics to Present at AACRPrecision Biologics, Inc. reports its lead monoclonal antibody, NEO-201, targets circulating human naïve regulatory T cells (Tregs) in...